31 August 2020 : Database Analysis
CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
Yiping Zou12CE, Shiye Ruan1CD, Liang Jin1C, Zhihong Chen1BF, Hongwei Han1DF, Yuanpeng Zhang1F, Zhixiang Jian1G, Ye Lin1D, Ning Shi1AE, Haosheng Jin1AG*DOI: 10.12659/MSM.925289
Med Sci Monit 2020; 26:e925289
Figure 6 (A) CDK1, CCNB1, and CCNB2 mutation rates were 6%, 9%, and 9%, respectively. (B, C) Genetic alterations in CDK1, CCNB1, and CCNB2 were associated with shorter overall survival (OS) and disease-free survival (DFS) of HCC patients.